Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia [Phase 1]

View source ↗

Summary

Phase 1 trial comparing insulin detemir with NPH insulin in type 1 diabetes; evaluates effects on blood sugar and hypoglycemia symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin detemir (insulin detemir)
  • Neutral protamine Hagedorn insulin (NPH) (insulin isophane)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED